LORINI, RENATA GIUSEPPINA
 Distribuzione geografica
Continente #
EU - Europa 20.362
Totale 20.362
Nazione #
IT - Italia 20.362
Totale 20.362
Città #
Genova 15.089
Rapallo 2.366
Genoa 1.529
Vado Ligure 1.326
Bordighera 52
Totale 20.362
Nome #
Diabetes incidence in 0- to 14-year age-group in Italy: a 10-year prospective study. 173
X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism: report on new mutation of the DAX-1 gene in two siblings 163
Younger age at onset and sex predict celiac disease in children and adolescents with type 1 diabetes: an Italian multicenter study. 162
Are psychobiological markers strongly correlated with allostatic load in population with autism spectrum disorders (ASD)? 154
Phenotype/Genotype Correlation and Cystic Fibrosis Related Diabetes Mellitus (Italian Multicenter Study) 152
13C-mixed triglyceride (13C-MTG) breath-test (BT) in Cystic Fibrosis (CF). 151
Adult height in patients with permanent growth hormone deficiency with and without multiple pituitary hormone deficiencies 150
No evidence of autoimmunity in 6-year-old children immunized at birth with recombinant hepatitis B vaccine 143
Impact of inhaled corticosteroids on the risk of early Pseudomonas Aeruginosa acquisition in cystic fibrosis 143
Matrix metalloproteinase 2 may be a marker of microangiopathy compared to metallo proteinase 9 in children and adolescents with type 1 diabetes mellitus: A 5 year follow-up study. 142
A telemedicine support for diabetes management: the T-IDDM project 140
Combined effects of room air treatment systems and intensive antibiotic therapy. 138
Nationwide cross-sectional survey of 3560 children and adolescents with diabetes in Italy. 136
Allergic sensitization and symptoms, body mass index, and respiratory function in children with type 1 diabetes mellitus. 136
Younger age at diagnosis of Type 1 diabetes mellitus in children of immigrated families born in Italy. 135
Molecular cytogenetic characterization of the first reported case of an inv dup (4p)(p15.1-pter) with a concomitant 4q35.1-qter deletion and normal parents. 135
Age-period-cohort analysis of 1990-2003 incidence time trends of childhood diabetes in Italy: the RIDI study. 134
Low total plasma homocysteine concentrations in patients with type 1 diabetes 132
Home nebulizer use and bacterial colonization in cystic fibrosis. 131
Diabetes mellitus after kidney transplantation in pediatric recipients 131
Outcome after depot gonadotrophin-releasing hormone agonist treatment for central precocious puberty: effects on body mass index and final height 130
A New SPINK5 Mutation in a Patient with Netherton Syndrome: A Case Report. 130
Long term persistence of anti-HBs protective levels in young patients with type 1 diabetes after recombinant hepatitis B vaccine. 128
Cerebellar atrophy without cerebellar cortex hyperintensity in infantile neuroaxonal dystrophy (INAD) due to PLA2G6 mutation. 128
Plasma and serum total homocysteine concentrations in paediatric patients, evaluated by high-performance liquid chromatography with fluorescence 127
Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes 126
Anti-CD38 autoimmunity in children with newly diagnosed type 1 diabetes mellitus 125
Matrix metalloproteinase 2 may be a marker of microangiopathy compared to metalloproteinase 9 in children and adolescents with type 1 diabetes mellitus: a 5-year follow-up study. 125
The IGF system in a case of Costello syndrome 125
Wolfram syndrome (diabetes insipidus, diabetes, optic atrophy, and deafness): clinical and genetic study. 124
Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an italian Cystic Fibrosis Center 124
Normal values of first -phase insulin response to intravenous glucose in healthy italian children and adolescents 124
The genetic abnormality in the beta cell determines the response to an oral glucose load 123
Blood Ketone bodies in patients with recent-onset type 1 diabetes (a multicenter study) 123
Discrepancy between sensitization to inhaled allergens and respiratory symptoms in pediatric patients with type 1 diabetes mellitus. 123
Mild hyperhomocysteinemia: vitamin supplementation or not? 122
High incidence of childhood type 1 diabetes in Liguria, Italy, from 1989 to 1998 122
May T1 diabetes mellitus protect from asthma? 122
Mother and daughter carrying the same KCNJ11 mutation but with a different response to switching from insulin to sulfonylurea. 122
Inflammation markers, lung function tests and exhaled nitric oxide levels in cystic fibrosis patients. 121
Risk of type 1 diabetes development in children with incidental hyperglycemia: a multicenter Italian study 121
Genetic investigation in an Italian child with an unusual association of atrial septal defect, attributable to a new familial GATA4 gene mutation, and neonatal diabetes due to pancreatic agenesis. 27(10):1195-200. 121
KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes. 120
Organ- and non-organ-specific auto-antibodies in children with hypopituitarism on growth hormone therapy. 120
Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young. 120
Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry. 119
Absence of sonic hedgehog (Shh) germline mutations in patients with thyroid dysgenesis. 119
Iperstaturalità. 118
A novel hepatocyte nuclear factor-1beta (MODY-5) gene mutation in an Italian family with renal dysfunctions and early-onset diabetes 118
Antibodies to tissue transglutaminase C in newly diagnosed and long-standing type 1 diabetes Mellitus 117
Antimicrobial use and Pseudomonas Aeruginosa susceptibility profile in a cystic fibrosis centre 117
Emerging effects of early environmental factors over genetic background for type 1 diabetes susceptibility: evidence from a Nationwide Italian Twin Study. 117
Use of continuous subcutaneous insulin infusion since the first weeks of pregnancy in five women with type 1 diabetes mellitus. 117
FùPhenotype-genotype correlation and cystic fibrosis related diabetes (CFRD) 116
Protocol-based reasoning in diabetic patient management. 115
Neuroimaging in Growth hormone deficiency 114
Hyperglycemia in celiac disease: not always pretype 1 diabetes? 114
Type 1 diabetes and epilepsy: more than a casual association? 113
The advantage of measuring spontaneous growth hormone (GH) secretion compared with the insulin tolerance test in the diagnosis of GH deficiency in young adults. 113
Wolfram syndrome: new mutations, different phenotype 112
Vitamin D receptor polymorphisms: are they really associated with type 1 diabetes? 111
Epilepsia partialis continua in type 1 diabetes: evolution into epileptic encephalopathy with continuous spike-waves during slow sleep 111
Idiopathic central diabetes insipidus in children and young adults is commonly associated with vasopressin-cell antibodies and markers of autoimmunity 111
Clinical aspects of coeliac disease in children with insulin-dependent diabetes mellitus 110
Comment on: Clinical application of best practice guidelines for genetic diagnosis of MODY2. 110
Alcaligenes xylosoxidans ed evoluzione della lesione polmonare in fibrosi cistica. 109
Variable phenotypic spectrum of diabetes mellitus in a family carrying a novel KCNJ11 gene mutation. 109
Auxological and metabolic study in small for gestational age children during 2 years follow-up. 109
GH response to ghrelin in subjects with congenital GH deficiency: evidence that ghrelin action requires hypothalamic-pituitary connections 109
Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects 108
Folic acid, vitamin B12 and homocysteine levels during fasting and after methionine load in patients wit type 1 diabetes mellitus. 107
High incidence of childhood Type 1 diabetes in Liguria (Italy) from 1989 to 1998 107
Length of gestation and gender are associated with HLA genotypes at risk for Type 1 diabetes (Italian DIABFIN 3). 107
Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes mellitus. 107
Re: Body mass index and allergic sensitization in children with asthma or type 1 diabetes. 107
Investigation of risk factors associated with different HLA genotypes of susceptibility to Type 1 diabetes (The DIABFIN Project). 106
The glucagon test in the diagnosis of growth hormone deficiency in children with short stature younger than 6 years. 106
Neonatal diabetes mellitus due to pancreatic agenesis and pervasive developmental disorder 106
Eating disorder in type 1 diabetes can be unmasked by information technology. 106
Type 1 diabetes risk for human leukocyte antigen (HLA)-DR3 haplotypes depends on genotypic context: association of DPB1 and HLA class I loci among DR3- and DR4-matched Italian patients and controls. 105
Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed Type 1 diabetes: a longitudinal study. 105
Autoimmunity, HLA, Gm and Km polymorphisms in Turner's syndrome. 105
Identification of novel WFS1 mutations in Italian children with Wolfram syndrome 105
Deterioration of growth hormone (GH) response and anterior pituitary function in young adults with childhood-onset GH deficiency and ectopic posterior pituitary: a two-year prospective follow-up study 104
Association of alleles at polymorphic sites in the osteopontin encoding gene in young type 1 diabetic patients 103
Pancreatic sufficiency and excellent pulmonary status in CF homozygotes for the R347P mutation. 103
Screening for type 1 diabetes genetic risk in newborns of continental Italy primary prevention (PREVEFIN Study) 103
Neutrophil myeloperoxidase (MPO) and eosinophil cationic protein (ECP) serum levels during steroid and antibiotic treatment in CF patients. 103
Increased adiposity at diagnosis in younger children with type 1 diabetes does not persist: response to Clarke et al. 102
Slow-release insulin in cystic fibrosis patients with glucose intolerance: a randomized clinical trial. 102
15 years of screening for BH4 deficiency in the Ligurian Region, Italy 101
Endocrine aspects of coeliac disease 101
Genetic prediction of type 1 diabetes in a population with low frequency of HLA risk genotypes and low incidence of the disease (the DIABFIN study). 101
Congenital hypothyroidism due to defects of thyroid development and mild increase of TSH at screening: data from the Italian National Registry of infants with congenital hypothyroidism. 100
Infiltrative entheropaty in children with gluten sensitization. 99
Plasma homocysteine concentrations in a school-age population 98
Strong association between time watching television and blood glucose control in children and adolescents with type 1 diabetes: response to Margeirsdottir et al. 98
Antipituitary antibodies in patients with pituitary abnormalities and hormonal deficiency. 98
The ALBA project: an evaluation of needs, management, fears of Italian young patients with type 1 diabetes in a school setting and an evaluation of parents' and teachers' perceptions. 98
Novel HESX1 mutations associated with a life-threatening neonatal phenotype, pituitary aplasia, but normally located posterior pituitary and no optic nerve abnormalities 98
Totale 11.904
Categoria #
all - tutte 51.759
article - articoli 37.656
book - libri 1.165
conference - conferenze 10.844
curatela - curatele 0
other - altro 384
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.710
Totale 103.518


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.218 0 0 0 0 0 464 1.090 254 422 964 760 264
2020/2021999 81 95 61 69 67 95 49 86 126 84 84 102
2021/20222.457 24 176 180 348 68 148 160 667 72 258 46 310
2022/20232.776 254 142 50 319 485 581 2 204 472 15 227 25
2023/20241.104 60 193 27 100 91 250 30 87 56 10 78 122
2024/20251.393 76 345 104 193 356 319 0 0 0 0 0 0
Totale 20.376